Home

Screener

Profile

ME Stock Price History and Quote Analysis: Insights for Investors

23andMe Holding Co.

(NASDAQ:ME)

$2.19

-0.09 (-3.95%)

At Close: 4:00 PM

$2.25

-0.03 (-1.32%)

Pre Market: 6:31 AM

ME Stock Price Graph

ME Stock Price Today

23andMe Holding Co. (ME) stock declined over -3.95% intraday to trade at $2.19 a share on NASDAQ. The stock opened with a loss of -0.88% at $2.26 and touched an intraday high of $2.29, falling -3.95% against the last close of $2.28. The 23andMe Holding Co. in stock market went to a low of $2.17 during the session.

ME Stock Snapshot

$2.28

Prev. Close

1.02 Billion

Market Cap

$2.17

Day Low

$2.26

Open

453.41 Million

Number of Shares

$2.29

Day High

P/E ratio

-1.20

EPS (TTM)

0.95

Cash Flow per Share

4.77

Free Float in %

1.62

Book Value

1,581,653

Volume

Contact Details

349 Oyster Point Boulevard
South San Francisco, CA 94080
United States

Website:https://www.23andme.com

Contact #:650 938 6300

About Company

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.

Frequently Asked Questions

What is the current 23andMe Holding Co. (ME) stock price?

23andMe Holding Co. (NASDAQ: ME) stock price is $2.19 in the last trading session. During the trading session, ME stock reached the peak price of $2.29 while $2.17 was the lowest point it dropped to. The percentage change in ME stock occurred in the recent session was -3.95% while the dollar amount for the price change in ME stock was -$0.09.

ME's industry and sector of operation?

The NASDAQ listed ME is part of Health Care Services industry that operates in the broader Health Care sector. 23andMe Holding Co. operates as a consumer genetics testing company.

Who are the executives of ME?

Ms. Anne Wojcicki
Co-Founder, Chief Executive Officer, Pres & Director
Dr. Wade Walke
Vice President of Investor Relations
Mr. Mike Polcari
Vice President & Chief Architect
Ms. Savita Pillai
Vice President of People

How ME did perform over past 52-week?

ME's closing price is 0.08% higher than its 52-week low of $2.02 where as its distance from 52-week high of $6.31 is -0.65%.

How many employees does ME have?

Number of ME employees currently stands at 728. ME operates from 349 Oyster Point Boulevard, South San Francisco, CA 94080, United States.

Link for ME official website?

Official Website of ME is: https://www.23andme.com

How do I contact ME?

ME could be contacted at phone #650 938 6300 and can also be accessed through its website. ME operates from 349 Oyster Point Boulevard, South San Francisco, CA 94080, United States.

How many shares of ME are traded daily?

ME stock volume for the day was 1,581,653 shares. The average number of ME shares traded daily for last 3 months was 2.31 Million.

What is the market cap of ME currently?

The market value of ME currently stands at $1.02 Billion with its latest stock price at $2.19 and 453.41 Million of its shares outstanding.